FINWIRES · TerminalLIVE
FINWIRES

BP通过与Cocuina-Manakin达成协议,扩大在委内瑞拉的天然气业务。

By

-- 英国石油公司(BP)周三与委内瑞拉签署了一份谅解备忘录,共同开发位于特立尼达和多巴哥附近的科库伊纳-马纳金(Cocuina-Manakin)天然气田。 该公司在回复的问询时表示,该协议在加拉加斯与委内瑞拉政府签署,确定了双方在海上天然气资源开发和未来勘探方面的潜在合作领域。 该公司称,该谅解备忘录是在本周BP高级代表团访问委内瑞拉期间签署的,该代表团由BP执行副总裁威廉·林(William Lin)率领。 据媒体报道,根据该协议,这家能源公司将主导开发位于特立尼达和多巴哥边境附近的科库伊纳-马纳金气田,同时评估洛兰(Loran)海上区块的其他勘探前景。 据报道,该合作还包括在洛兰地区开展联合勘探和天然气商业化工作,包括壳牌(SHEL)在内的其他全球企业对该地区的兴趣持续增长。 据多家媒体报道,委内瑞拉加快了吸引外国运营商的步伐,与埃尼集团(Eni)和雷普索尔公司(Repsol)等企业签署了新的协议,以扩大上游产能。 该谅解备忘录规定了在天然气开发和未来勘探项目方面的合作,委内瑞拉国家石油公司(Petroleos de Venezuela)也包含在内。 据报道,林表示,该公司正在通过在加拉加斯设立常驻办事处来加强其在委内瑞拉的业务。 该协议是在加拉加斯举行的大型能源会议之后签署的,该会议吸引了全球投资者,各公司正在推进长期计划,包括预计将于2031年左右启动的天然气出口项目。 报道还称,英国石油公司(BP)计划将该气田超过1万亿立方英尺的天然气输送到特立尼达,加工成液化天然气出口,从而加强区域供应链。

Price: $47.23, Change: $+0.43, Percent Change: +0.92%

Related Articles

Sectors

Sector Update: Financial

Financial stocks were higher late Thursday afternoon, with the NYSE Financial Index rising 1.3% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.5%.The Philadelphia Housing Index climbed 1.6%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1.5%.Bitcoin (BTC-USD) rose 0.9% to $76,409, and the yield for 10-year US Treasuries decreased 2.8 basis points to 4.39%.In corporate news, AvalonBay Communities (AVB) and Equity Residential (EQR) have held discussions over a potential merger, which would be one of the biggest real estate deals ever, Bloomberg reported. AvalonBay shares were down 1.1%, and Equity Residential was fractionally lower.

$AVB$EQR
Australia

Market Chatter: Zuckerberg, Cook Not Exploring Seattle Seahawks Bid

Meta Platforms (META) CEO Mark Zuckerberg and Apple (AAPL) CEO Tim Cook are not pursuing a bid for the National Football League's Seattle Seahawks, Bloomberg reported on Thursday, citing company and industry sources.A Meta spokesperson said Zuckerberg is not making any investment or bid for the team, while a person familiar with Cook's plans denied his involvement, the report said.Meta and Apple did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics Says FDA Approves Auvelity for Alzheimer's Disease Agitation

Axsome Therapeutics (AXSM) said Thursday the US Food and Drug Administration approved Auvelity for the treatment of agitation associated with Alzheimer's disease dementia.The approval was supported by two phase 3 clinical trials that showed the drug significantly improved agitation symptoms and resulted in a longer time to relapse compared with placebo.The medication acts on N-methyl-D-aspartate and sigma-1 receptors in the brain and is also approved for adults with major depressive disorder, the company added.Shares of Axsome were up more than 12% in Thursday trading.Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM